Study on heart and lung effects of BPA in CTEPH
Part of Heart & circulation, Lungs & breathing clinical trials.
This study uses special heart scans (CMR with 4D flow) to see how a procedure called BPA affects blood flow in the heart and lungs for people with a rare type of high blood pressure in the lungs (CTEPH). It may help doctors understand how well BPA works beyond just symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been referred for a procedure called BPA (balloon pulmonary angioplasty) to treat a chronic blood clot condition in your lungs (CTEPH).
- Your doctor has recommended you get an MRI scan of your heart (called CMR).
- You are able to understand and agree to the study (give informed consent).
- You are 18 years old or older.
- You are not pregnant.
- You do not have a medical device that is not safe for MRI (like certain pacemakers) or severe kidney disease (eGFR below 30) or allergies to the medications used in the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a minimally invasive procedure called balloon pulmonary angioplasty (BPA) helps patients with chronic blood clots in the lungs improve their heart function and overall recovery. Researchers will measure blood flow patterns in your arteries before and after the procedure to understand how well your heart recovers.
This study looks at how CTEPH (a type of high blood pressure in the lungs caused by blood clots) affects heart function differently in men and women. It uses heart ultrasounds and pressure measurements to see if recovery after surgery differs by sex.
This study looks at patterns from specialized lung scan tests to help diagnose chronic thromboembolic pulmonary hypertension (a long-term problem with blood flow in the lungs after blood clots). If your results suggest this condition and you need a procedure to check heart pressure, you may be asked to join so the researchers can improve diagnosis.
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
This study looks at whether a special CT scan of the lungs (CT pulmonary angiography) can give results similar to a more invasive heart catheterization test for measuring blood pressure in the lungs. It may help doctors diagnose and monitor pulmonary hypertension more easily in the future.
This study tests if a small sensor placed in your lung artery during surgery can safely help doctors watch for remaining high blood pressure after the operation. It may help catch problems earlier, but it is a small exploratory study for people at higher risk of having this issue.
Hear when a new CTEPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.